Editas Medicine Inc (EDIT) Beta: Monthly Comparison and Analysis

Editas Medicine Inc (NASDAQ: EDIT) closed the day trading at $9.08 down -0.66% from the previous closing price of $9.14. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 1866068 shares were traded.

Ratios:

For a better understanding of EDIT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.39 and its Current Ratio is at 5.39. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.07.

On October 18, 2023, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $8.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’24 when O’Neill Gilmore Neil sold 77,824 shares for $9.42 per share. The transaction valued at 732,884 led to the insider holds 327,470 shares of the business.

Mei Baisong sold 20,327 shares of EDIT for $191,425 on Mar 04 ’24. The SVP, CHIEF MEDICAL OFFICER now owns 141,543 shares after completing the transaction at $9.42 per share. On Dec 05 ’23, another insider, Eaton Bruce, who serves as the EVP, CBO AND CTO of the company, sold 103 shares for $10.90 each. As a result, the insider received 1,122 and left with 74,791 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 746.50M and an Enterprise Value of 459.92M. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.51 while its Price-to-Book (P/B) ratio in mrq is 2.13. Its current Enterprise Value per Revenue stands at 5.89 whereas that against EBITDA is -2.82.

Stock Price History:

Over the past 52 weeks, EDIT has reached a high of $11.91, while it has fallen to a 52-week low of $6.08. The 50-Day Moving Average of the stock is 8.64, while the 200-Day Moving Average is calculated to be 8.69.

Shares Statistics:

Over the past 3-months, EDIT traded about 1.94M shares per day on average, while over the past 10 days, EDIT traded about 2.66M shares per day. A total of 81.77M shares are outstanding, with a floating share count of 81.19M. Insiders hold about 0.76% of the company’s shares, while institutions hold 73.22% stake in the company. Shares short for EDIT as of Feb 15, 2024 were 12.59M with a Short Ratio of 6.48, compared to 12.48M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 15.41% and a Short% of Float of 21.67%.

Earnings Estimates

Current recommendations for the stock of the company come from 15 analysts. On average, analysts expect EPS of -$0.66 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$1.09, while EPS last year was -$0.71. The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.46 and low estimates of -$1.11.

Analysts are recommending an EPS of between -$1.84 and -$3.83 for the fiscal current year, implying an average EPS of -$2.66. EPS for the following year is -$2.7, with 16 analysts recommending between -$1.73 and -$4.51.

Most Popular

[the_ad id="945"]